Biotechnology in the Time of COVID-19: Commentaries from the Front Line

by Jeremy M. Levin

To put this challenge into context, consider that today we are not even fully successful in immunizing the world’s birth cohort for vaccine-preventable childhood diseases, despite decades of advocacy, effort, and investment.